首页 > 市场调查报告书 > 医疗设备

生技设备癌症

市场调查报告书

商品编码

1454151

全球癌症肿瘤分析市场规模、份额、成长分析（按技术、癌症类型）- 产业预测，2024-2031 年

Global Cancer Tumor Profiling Market Size, Share, Growth Analysis, By Technology(Breast cancer, Lung cancer), By Cancer type(genomic biomarker, protein biomarker) - Industry Forecast 2024-2031

出版日期: 2024年03月11日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

癌症肿瘤分析的全球市场规模预计在 2022 年达到 107.3 亿美元，从 2023 年的 118.7 亿美元增长到 2031 年的 26.5 亿美元，预测期内（2024-2031 年）复合年增长率为 10.6%。至7 千万美元。

推动癌症肿瘤分析市场的关键因素是全球癌症患者数量的增加以及生物标记在肿瘤分析中的应用。由于癌症研究、资助计划和技术开发投资的增加，癌症肿瘤分析市场正在扩大。对于市场参与企业来说，照护现场和个人化医疗的扩展预计将在未来几年提供重大机会。

预计 2020-2021 年 COVID-19 大流行不会对癌症肿瘤分析产业产生重大影响。由于采取了针对病毒的预防措施，COVID-19 大流行显着减少了癌症检测和诊断。蛋白质体学、磊晶、代谢体学和基因组学是癌症肿瘤分析市场预测期内的细分领域。其中，基因组学预计年复合成长率最高（19.7%）。此方法确定整个基因组内的基因是异常还是正常。它用于阐明基因的特征。基因可以透过突变异常发育并帮助癌细胞生存。一种有前途的识别和研究癌症的方法被称为癌症肿瘤分析，它检查肿瘤型态、代谢和阶段的变化。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

Illumina, Inc.
Thermo Fisher Scientific, Inc.
QIAGEN NV
F. Hoffmann-La Roche AG
Agilent Technologies, Inc.
Myriad Genetics, Inc.
Personal Genome Diagnostics Inc.
Foundation Medicine, Inc.
Guardant Health, Inc.
NanoString Technologies, Inc.
Genomic Health, Inc.
Adaptive Biotechnologies Corporation
Caris Life Sciences
Becton, Dickinson and Company
PerkinElmer, Inc.
Natera, Inc.
Oxford Nanopore Technologies
Biocartis Group NV
ArcherDX, Inc.
Sysmex Corporation

简介目录

Product Code: SQMIG35G2114

Global Cancer Tumor Profiling Market size was valued at USD 10.73 billion in 2022 and is poised to grow from USD 11.87 billion in 2023 to USD 26.57 billion by 2031, at a CAGR of 10.6% during the forecast period (2024-2031).

The main drivers propelling the market for cancer detection and treatment products are the global increase in cancer cases and the application of biomarkers in tumor profiling. The market for cancer and tumor profiling has expanded as a result of increased investments in cancer research, funding programs, and technology developments. For market participants, the expansion of point-of-care diagnostics and personalized medicine is anticipated to present substantial potential over the next years.

The COVID-19 pandemic in 2020-2021 is not anticipated to have a major effect on the cancer/tumor profiling industry. As a result of precautions made to guard against the virus, the COVID-19 epidemic has significantly reduced the amount of cancer testing and diagnoses. Proteomics, epigenetics, metabolomics, and genomics are the segments of the cancer/tumor profiling market that will be included in the forecast period. Of these, genomics is anticipated to have the greatest compound annual growth rate (19.7%). The method establishes if a gene within the entire genome is aberrant or normal. It is used to characterize genes. Genes develop abnormally due to mutations, which can aid in the survival of cancer cells. A promising method for identifying and researching cancer is cancer tumor profiling, which looks for alterations in tumor shape, metabolism, and stage.

Top-down and bottom-up approaches were used to estimate and validate the size of Global Cancer Tumor Profiling Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Logistics Automation Market Segmental Analysis

The market for cancer tumor profiling is divided into segments based on according to application, biomarker, cancer kind, and technology. On the other hand, technology is divided into categories such as microarrays, mass spectrometry, in-situ hybridization, polymerase chain reaction, next-generation sequencing, and immunoassays.Breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma cancer, and other cancer types are divided into different categories. Protein biomarkers and genetic biomarkers are the two categories of biomarkers. Application is divided into two categories: research and biomarker identification. The market is divided into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

Drivers of Global Cancer Tumor Profiling Market

One of the main factors driving market expansion in the overall cancer/tumor profiling industry is the rise in cancer incidences. Numerous causes contribute to the rising incidence of cancer. The disease is broad and complex, with multiple etiologies. The incidence of cancer is influenced by factors such as aging populations, increasing population sizes, and shifting rates of certain cancer causes.

Restraints in Global Cancer Tumor Profiling Market

In the cancer and tumor profiling industry, technical problems with sample collection and storage are impeding market expansion. A rapidly expanding area of medicine called "personalized medicine" is revolutionizing the diagnosis, categorization, and management of numerous illnesses. The way diseases are treated is already significantly changing as a result of the widespread adoption of this strategy in clinical practice. Oncology is one field where recent advancements in cancer treatment are very noticeable. Their associated risks may impede market expansion.

Market Trends of Global Cancer Tumor Profiling Market

The integration of omics data and developments in liquid biopsy tests are anticipated to drive the greatest compound annual growth rate (CAGR) in the cancer/tumor profiling market over the projected period. The topic of personalized medicine is a rapidly expanding area of healthcare study that is revolutionizing the diagnosis, classification, and treatment of diseases. It is currently utilized to treat a wide range of illnesses and has entered the mainstream of clinical practice. Oncology is one field where the advancements in cancer treatment are most noticeable.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Cancer Tumor Profiling Market by Technology

Market Overview
Breast cancer
Lung cancer
Colorectal cancer

Global Cancer Tumor Profiling Market by Cancer type

Market Overview
genomic biomarker
protein biomarker

Global Cancer Tumor Profiling Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Illumina, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Personal Genome Diagnostics Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Foundation Medicine, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guardant Health, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NanoString Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genomic Health, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Adaptive Biotechnologies Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Caris Life Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Natera, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Nanopore Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocartis Group NV
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ArcherDX, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments